相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy and safety of bempedoic acid in patients not receiving statins in phase 3 clinical trials
Ulrich Laufs et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2022)
Statin treatment and muscle symptoms: series of randomised, placebo controlled n-of-1 trials
Emily Herrett et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
Role of Bempedoic Acid in Clinical Practice
Christie M. Ballantyne et al.
CARDIOVASCULAR DRUGS AND THERAPY (2021)
Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy
Christie M. Ballantyne et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2020)
Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol
Kausik K. Ray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Pharmacogenetics of Statin-Induced Myotoxicity
Ping Siu Kee et al.
FRONTIERS IN GENETICS (2020)
N-of-1 Trial of a Statin, Placebo, or No Treatment to Assess Side Effects
Frances A. Wood et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol
Kausik K. Ray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Effect of Bempedoic Acid vs Placebo Added to Maximally Tolerated Statins on Low-Density Lipoprotein Cholesterol in Patients at High Risk for Cardiovascular Disease: The CLEAR Wisdom Randomized Clinical Trial
Anne C. Goldberg et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Coenzyme q10 liquid supplementation in dyslipidemic subjects with statin-related clinical symptoms: a double-blind, randomized, placebo-controlled study
Giuseppe Derosa et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2019)
Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association
Connie B. Newman et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2019)
Statin Toxicity Mechanistic Insights and Clinical Implications
Natalie C. Ward et al.
CIRCULATION RESEARCH (2019)
Effects of vitamin D supplementation on adherence to and persistence with long-term statin therapy: Secondary analysis from the randomized, double-blind, placebo-controlled ViDA study
Zhenqiang Wu et al.
ATHEROSCLEROSIS (2018)
Efficacy and safety of bempedoic acid added to ezetimibe in statin-intolerant patients with hypercholesterolemia: A randomized, placebo-controlled study
Christie M. Ballantyne et al.
ATHEROSCLEROSIS (2018)
Does Googling lead to statin intolerance?
Sarah Khan et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2018)
PCSK9 Inhibitors: Mechanism of Action, Efficacy, and Safety
Eli M. Roth et al.
REVIEWS IN CARDIOVASCULAR MEDICINE (2018)
Statin-Associated Autoimmune Myopathy: A Systematic Review of 100 Cases
Salik Nazir et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2017)
Statin-associated muscle symptoms-Managing the highly intolerant
James M. Backes et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2017)
Vitamin D and muscle function
Bess Dawson-Hughes
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2017)
Low vitamin D does not predict statin associated muscle symptoms but is associated with transient increases in muscle damage and pain
Beth A. Taylor et al.
ATHEROSCLEROSIS (2017)
Negative statin-related news stories decrease statin persistence and increase myocardial infarction and cardiovascular mortality: a nationwide prospective cohort study
Sune Fallgaard Nielsen et al.
EUROPEAN HEART JOURNAL (2016)
Recommendations for Management of Clinically Significant Drug-Drug Interactions With Statins and Select Agents Used in Patients With Cardiovascular Disease A Scientific Statement From the American Heart Association
Barbara S. Wiggins et al.
CIRCULATION (2016)
Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance The GAUSS-3 Randomized Clinical Trial
Steven E. Nissen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
The nocebo effect in the context of statin intolerance
Jonathan A. Tobert et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2016)
Mechanism of Drug-Drug Interactions Between Warfarin and Statins
Abdul Naveed Shaik et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2016)
Statin-Associated Side Effects
Paul D. Thompson et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Interpretation of the evidence for the efficacy and safety of statin therapy
Rory Collins et al.
LANCET (2016)
Statin-Associated Autoimmune Myopathy
Andrew L. Mammen
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Discontinuation and restarting in patients on statin treatment: prospective open cohort study using a primary care database
Yana Vinogradova et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Discontinuation and restarting in patients on statin treatment: prospective open cohort study using a primary care database
Yana Vinogradova et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
A randomized trial of coenzyme Q10 in patients with confirmed Statin Myopathy
Beth A. Taylor et al.
ATHEROSCLEROSIS (2015)
Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management
Erik S. Stroes et al.
EUROPEAN HEART JOURNAL (2015)
Impact of ABCG2 and SLCO1B1 polymorphisms on pharmacokinetics of rosuvastatin, atorvastatin and simvastatin acid in Caucasian and Asian subjects: a class effect?
Bruce K. Birmingham et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Efficacy and safety of alirocumab vs ezetimibe in statin-intolerant patients, with a statin rechallenge arm: The ODYSSEY ALTERNATIVE randomized trial
Patrick M. Moriarty et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2015)
Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events
Jennifer G. Robinson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular Events
Marc S. Sabatine et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
Christopher P. Cannon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
N-of-1 (Single-Patient) Trials for Statin-Related Myalgia
Tisha R. Joy et al.
ANNALS OF INTERNAL MEDICINE (2014)
An assessment by the Statin Muscle Safety Task Force: 2014 update
Robert S. Rosenson et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2014)
An assessment by the Statin Intolerance Panel: 2014 update
John R. Guyton et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2014)
The pharmacology of statins
Cesare R. Sirtori
PHARMACOLOGICAL RESEARCH (2014)
Discontinuation of Statins in Routine Care Settings A Cohort Study
Huabing Zhang et al.
ANNALS OF INTERNAL MEDICINE (2013)
Predictors of statin adherence, switching, and discontinuation in the USAGE survey: Understanding the use of statins in America and gaps in patient education
Melissa Y. Wei et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2013)
Long-Term Effects of Statin Treatment in Elderly People: Extended Follow-Up of the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER)
Suzanne M. Lloyd et al.
PLOS ONE (2013)
Effects of polymorphisms in ABCG2, SLCO1B1, SLC10A1 and CYP2C9/19 on plasma concentrations of rosuvastatin and lipid response in Chinese patients
Hon-Kit Lee et al.
PHARMACOGENOMICS (2013)
Effect of Coenzyme Q10 Supplementation on Stalin-Induced Myalgias
David A. Bookstaver et al.
AMERICAN JOURNAL OF CARDIOLOGY (2012)
Antibody Levels Correlate With Creatine Kinase Levels and Strength in Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase-Associated Autoimmune Myopathy
Jessie L. Werner et al.
ARTHRITIS AND RHEUMATISM (2012)
Muscle pain and serum creatine kinase are not associated with low serum 25(OH) vitamin D levels in patients receiving statins
Daniel Kurnik et al.
CLINICAL ENDOCRINOLOGY (2012)
Understanding Statin Use in America and Gaps in Patient Education (USAGE): An internet-based survey of 10,138 current and former statin users
Jerome D. Cohen et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2012)
Rosuvastatin for Primary Prevention in Older Persons With Elevated C-Reactive Protein and Low to Average Low-Density Lipoprotein Cholesterol Levels: Exploratory Analysis of a Randomized Trial
Robert J. Glynn et al.
ANNALS OF INTERNAL MEDICINE (2010)
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
C. Baigent et al.
LANCET (2010)
Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12 064 survivors of myocardial infarction: a double-blind randomised trial
Jane Armitage et al.
LANCET (2010)
Effectiveness and tolerability of every-other-day rosuvastatin dosing in patients with prior statin intolerance
James M. Backes et al.
ANNALS OF PHARMACOTHERAPY (2008)
SLCO1B1Variants and Statin-Induced Myopathy — A Genomewide Study
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Paul M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Analysis of efficacy and safety in patients aged 65-75 years at randomization - Collaborative Atorvastatin Diabetes Study (CARDS)
H. Andrew W. Neil et al.
DIABETES CARE (2006)
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins
C Baigent et al.
LANCET (2005)
Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs
DJ Graham et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
分享论文
